Responding to simulated pandemic influenza in San Antonio, Texas

Infection Control and Hospital Epidemiology

Volumn 29, Issue 4, 2008, Pages 320-326

  Miller, George ^a   Randolph, Stephen ^c   Patterson, Jan E ^b  

^a ALTARUM INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ALTARUM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; HEALTH CARE PLANNING; HUMAN; INFLUENZA; PANDEMIC; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; COMPUTER SIMULATION; DISASTER PLANNING; DISEASE OUTBREAKS; HUMANS; INFLUENZA, HUMAN; MIDDLE AGED; MODELS, BIOLOGICAL; QUARANTINE; TEXAS;

EID: 40949084833     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/529212     Document Type: Article

References (26)

1. Leitenberg M. Assessing the biological weapons and bioterrorism threat. Strategic Studies Institute, US Army War College, 2005. Available at: http://www.cissm.umd.edu/papers/files/assessing_bw_threat.pdf. Accessed December 28, 2006.
2. US General Accounting Office. Bioterrorism, Federal Research and Preparedness Activities. Washington, DC: US General Accounting Office; 2001:22. GAO-01-915.
3. Miller G, Randolph S, Gower D. Simulating the response of a rural acute health-care delivery system to a bioterrorist attack. Intl J Disaster Med 2004; 2:24-32.
4. Miller G, Randolph S, Patterson JE. Responding to bioterrorist smallpox in San Antonio. Interfaces 2006; 36:580-590.
5. Elveback LR, Fox JP, Ackerman E, Langworthy A, Boyd M, Gatewood L. An influenza simulation model for immunization studies. Am J Epidemiol 1976; 103:152-165.
6. Cunha B. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 2004; 18:141-155.
7. Billings M. The Influenza Pandemic of 1918. June 1997. Available at: http://virus.stanford.edu/uda/. Accessed December 15, 2006.
8. Homeland Security Council. National Strategy for Pandemic Influenza. Washington, DC: Homeland Security Council; November 2005.
9. US Department of Health and Human Services. HHS Pandemic Influenza Plan. Washington, DC: US Dept of Health and Human Services; November 2005.
10. Bootsma CJ, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in US cities. 2007. Available at: http://www.pnas.org/cgi/ doi/10.1073/pnas.0611071104. Accessed May 1, 2007.
11. Longini IM Jr, Nizam A, Xu S, et al. Containing pandemic influenza at the source. Science 2005; 309:1083-1087.
12. Ferguson NM, Cummings DAT, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437:209-214.
13. Germann TC, Kadau K, Longini IM Jr, Macken CA. Mitigation measures for pandemic influenza in the United States. Proc Natl Acad Sci U S A 2006; 103:5935-5940.
14. US Department of Health and Human Services, Centers for Disease Control and Prevention. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States. February 2007. Available at: http://www.pandemicflu.gov/plan/community/mitigation.html. Accessed February 26, 2007.
15. 2000 US Census. Available at: http://www.census.gov/population/www/ projections/st_yr01to05.html. Accessed July 14, 2006.
16. Randolph S, Miller G. Validation of the Casualty Prediction Model. Altarum Institute. July 2007. Available at: http://www.altarum.org/FCKeditor/ UserFiles/File/CPMValidation_ib.pdf. Accessed November 19, 2007.
17. Longini IM, Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza. Am J Epidemiol 1982; 115:736-751.
18. Longini IM, Koopman JS, Haber M, Cotsonis GA. Statistical inference for infectious diseases, risk-specific household and community transmission parameters. Am J Epidemiol 1988; 128:845-859.
19. Barnitz L. The Health Care Response to Pandemic Influenza: A Position Paper. Washington, DC: American College of Physicians; 2006.
20. Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S. Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis 2005; 11:1355-1362.
21. Longini IM, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004; 159:623-633.
22. Patterson JE. SARS in Toronto: what does it mean for us? [commentary] Contagion 2005; 2:1-4.
23. Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006; 194:S119-S126.
24. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006; 354:1343-1351.
25. Markel H, Lipman HB, Navarro JA, et al. Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. JAMA 2007; 298:644-654.
26. Markel H, Stern AM, Navarro JA, Michalsen JR. A historical assessment of nonpharmaceutical disease containment strategies employed by selected US communities during the wave of the 1918-1920 influenza pandemic. Defense Threat Reduction Agency, January 31, 2006. Available at: http://www.med.umich.edu/ medschool/chm/influenza/. Accessed August 13, 2007.